W
William R. Keller
Researcher at University of Maryland, Baltimore
Publications - 21
Citations - 2182
William R. Keller is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Schizophrenia & Schizophrenia (object-oriented programming). The author has an hindex of 14, co-authored 20 publications receiving 1935 citations.
Papers
More filters
Journal ArticleDOI
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Robert W. Buchanan,Julie Kreyenbuhl,Julie Kreyenbuhl,Deanna L. Kelly,Jason M. Noel,Douglas L. Boggs,Bernard A. Fischer,Seth Himelhoch,Beverly Fang,Eunice Peterson,Patrick R. Aquino,William R. Keller +11 more
TL;DR: An extensive literature review was conducted to determine whether the current psychopharmacological treatment recommendations required revision and whether there was sufficient evidence to warrant new treatment recommendations for prespecified outcomes of interest.
Journal ArticleDOI
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.
Gregory P. Strauss,William P. Horan,Brian Kirkpatrick,Bernard A. Fischer,Bernard A. Fischer,William R. Keller,Pinar Miski,Robert W. Buchanan,Robert W. Buchanan,Michael F. Green,William T. Carpenter,William T. Carpenter +11 more
TL;DR: It is suggested that distinct subgroups of patients with elevated AA or DE can be identified within the broader diagnosis of schizophrenia and that these subgroups show clinically meaningful differences in presentation.
Journal ArticleDOI
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Robert W. Buchanan,Julie Kreyenbuhl,Julie Kreyenbuhl,Deanna L. Kelly,Jason M. Noel,Douglas L. Boggs,Bernard A. Fischer,Seth Himelhoch,Beverly Fang,Eunice Peterson,Patrick R. Aquino,William R. Keller +11 more
TL;DR: An extensive literature review was conducted to determine whether the current psychopharmacological treatment recommendations required revision and whether there was sufficient evidence to warrant new treatment recommendations for prespecified outcomes of interest.
Journal ArticleDOI
Factor structure of the brief negative symptom scale
Gregory P. Strauss,L. Elliot Hong,James M. Gold,Robert W. Buchanan,Robert P. McMahon,William R. Keller,Bernard A. Fischer,Lauren T. Catalano,Adam J. Culbreth,William T. Carpenter,Brian Kirkpatrick +10 more
TL;DR: The current study examined the factor structure of the Brief Negative Symptom Scale, a next-generation negative symptom rating instrument developed in response to the NIMH-sponsored Consensus Development Conference on Negative Symptoms.
Journal ArticleDOI
Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.
Gregory P. Strauss,William R. Keller,Robert W. Buchanan,James M. Gold,Bernard A. Fischer,Robert P. McMahon,Lauren T. Catalano,Adam J. Culbreth,William T. Carpenter,Brian Kirkpatrick +9 more
TL;DR: Results indicated that the BNSS has excellent internal consistency and temporal stability, as well as good convergent and discriminant validity in its relationships with other symptom rating scales, functional outcome, self-reported anhedonia, and neuropsychological test scores.